MannKind Corp (MNKD): Cost of Revenue
$26.80M
Year ended 2025-12-31
$40.34M
Trailing 12 months to 2026-06-30
+18.8%
3-year compound annual growth
+12.2%
5-year compound annual growth
-8.4%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $26.80M | +53.8% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $17.43M | -16.5% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $20.86M | +30.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $16.00M | -4.9% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $16.83M | +11.6% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $15.08M | -24.9% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $20.08M | +3.5% | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | $19.39M | +12.6% | 2020-02-25, From 2018-01-01 |
| 2017-12-31 | $17.23M | +0.6% | 2019-02-26, From 2017-01-01 |
| 2016-12-31 | $17.12M | -73.6% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $64.75M | n/a | 2018-02-27, From 2015-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| MannKind Corp (MNKD) | 2025-12-31 | $26.80M | +53.8% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $36.70M | +91.8% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $124.03M | -11.8% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $22.09M | +628.0% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $39.54M | -21.8% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $100.07M | +19.2% |
| Harrow, Inc. (HROW) | 2025-12-31 | $67.93M | +38.0% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $190.52M | +29.5% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $113.25M | +50.1% |
Compare MNKD, ARQT, SVA, CRMD side by side · Screen every company in Pharmaceutical Preparations ↗